Holen Sie sich die Stockscreener-App
10.50
1.41%
-0.15
Handel nachbörslich:
10.50
Schlusskurs vom Vortag:
$10.65
Offen:
$10.66
24-Stunden-Volumen:
78,326
Relative Volume:
0.90
Marktkapitalisierung:
$171.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.82M
KGV:
-0.4103
EPS:
-25.5891
Netto-Cashflow:
$-66.04M
1W Leistung:
-2.69%
1M Leistung:
-8.70%
6M Leistung:
+113.41%
1J Leistung:
+127.77%
1-Tages-Spanne:
$10.40
$10.70
1-Wochen-Bereich:
$10.37
$11.19
52-Wochen-Spanne:
$4.05
$12.62
Elicio Therapeutics Inc Stock (ELTX) Company Profile
Firmenname
Elicio Therapeutics Inc
Sektor
Branche
Telefon
(857) 209-0050
Adresse
451 D STREET, 5TH FLOOR, BOSTON
Vergleichen Sie ELTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELTX
Elicio Therapeutics Inc
|
10.50 | 174.00M | 0 | -33.82M | -66.04M | -25.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Smart tools for monitoring Elicio Therapeutics Inc.’s price actionTreasury Yields & Real-Time Volume Triggers - newser.com
How Elicio Therapeutics Inc. stock compares to market leadersJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com
Using AI based signals to follow Elicio Therapeutics Inc.CPI Data & Capital Protection Trade Alerts - newser.com
How Elicio Therapeutics Inc. (9HA) stock compares with market leaders2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Using data models to predict Elicio Therapeutics Inc. stock movementWeekly Risk Report & Safe Entry Momentum Tips - newser.com
Can Elicio Therapeutics Inc. hit a new high this monthJuly 2025 Review & AI Optimized Trade Strategies - newser.com
What makes Elicio Therapeutics Inc. (9HA) stock appealing to growth investors2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
What machine learning models say about Elicio Therapeutics Inc.2025 EndofYear Setup & Precise Swing Trade Alerts - newser.com
What momentum shifts mean for Elicio Therapeutics Inc.2025 Momentum Check & Risk Controlled Stock Pick Alerts - newser.com
Volatility clustering patterns for Elicio Therapeutics Inc.2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Is Elicio Therapeutics Inc. stock oversold or undervaluedShort Setup & Capital Efficient Trade Techniques - newser.com
Is this a good reentry point in Elicio Therapeutics Inc.2025 Price Action Summary & Free Technical Pattern Based Buy Signals - newser.com
Using R and stats models for Elicio Therapeutics Inc. forecastingJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Ranking Elicio Therapeutics Inc. among high performing stocks via toolsTrade Risk Report & Daily Price Action Insights - newser.com
Elicio Therapeutics Inc. stock chart pattern explainedWeekly Gains Report & Entry Point Strategy Guides - newser.com
Real time alert setup for Elicio Therapeutics Inc. performanceWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
What high frequency data says about Elicio Therapeutics Inc.2025 Analyst Calls & Technical Pattern Alert System - newser.com
Is Elicio Therapeutics Inc. (9HA) stock attractive for growth fundsCEO Change & Low Risk High Win Rate Stock Picks - newser.com
What margin trends mean for Elicio Therapeutics Inc. stockJuly 2025 Snapshot & Daily Entry Point Alerts - newser.com
Identifying reversal signals in Elicio Therapeutics Inc.Weekly Investment Summary & Free Real-Time Volume Trigger Notifications - newser.com
Detecting price anomalies in Elicio Therapeutics Inc. with AIPortfolio Update Report & Verified Technical Trade Signals - newser.com
Why Elicio Therapeutics Inc. (9HA) stock stays undervaluedTrade Analysis Report & Verified Entry Point Signals - newser.com
Is Elicio Therapeutics Inc. (9HA) stock a contrarian opportunityQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Applying Elliott Wave Theory to Elicio Therapeutics Inc.July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Top chart patterns to watch in Elicio Therapeutics Inc.Quarterly Earnings Summary & Daily Technical Forecast Reports - newser.com
How to use a screener to detect Elicio Therapeutics Inc. breakoutsMarket Activity Recap & Risk Managed Trade Strategies - newser.com
Is Elicio Therapeutics Inc. stock supported by strong fundamentalsJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com
How Elicio Therapeutics Inc. (9HA) stock reacts to fiscal policiesEarnings Overview Summary & Daily Profit Maximizing Tips - newser.com
How sentiment analysis helps forecast Elicio Therapeutics Inc.Quarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com
What technical models suggest about Elicio Therapeutics Inc.’s comebackMarket Performance Recap & Real-Time Stock Price Movement Reports - newser.com
How moving averages guide Elicio Therapeutics Inc. tradingJuly 2025 WrapUp & Long-Term Safe Return Strategies - newser.com
Is Elicio Therapeutics Inc. still worth holding after the dip2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):